MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-AP-10-0000094
Enanti Labs Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹62.07 Cr
▼ 14% YoY
Net profit · FY 2025
₹75.35 Lakh
Net margin 1.2%
EBITDA · FY 2025
₹4.72 Cr
EBITDA margin 7.6%
Authorised capital
₹7 Cr
Registered with MCA
Paid-up capital
₹5.55 Cr
Issued & subscribed
Open charges
₹32.96 Cr
Satisfied ₹40.42 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
169
Provident fund records
About Enanti Labs Private Limited
Data last updated:
Enanti Labs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 July 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24119TG2006PTC050537. Its GSTIN is 37AABCE6229K1ZG (Andhra Pradesh).
The company has an authorised share capital of ₹7 Cr and a paid-up capital of ₹5.55 Cr. It is led by directors including Mandapati Satyanarayana Reddy (Managing Director) and Chandra Sekhara Reddi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No. 201 Plot No. 10 Vivekananda Nagar Colony, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹62.07 Cr, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹75.35 Lakh (net margin 1.2%) and EBITDA of ₹4.72 Cr (EBITDA margin 7.6%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 6% over five years.
The company has about 169 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Enanti Labs. As per MCA filings, the company has open charges of ₹32.96 Cr and satisfied charges of ₹40.42 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending. The company has 12 deals on record (8 secondary share transfers, 4 funding rounds), with disclosed funding of ₹6.67 Cr; the latest was in July 2021. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Preet Remedies Limited with revenue of ₹62.83 Cr.
Enanti Labs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0000094). The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website enantilabs.com.
Company details
CIN U24119TG2006PTC050537
Registration Number 050537
Incorporation Date 05 July 2006
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Non-Compliant
MSME Classification Medium
Udyam Registration UDYAM-AP-10-0000094
CIN history
Enanti Labs has one previous CIN (Corporate Identification Number): U24119AP2006PTC050537. The current CIN is U24119TG2006PTC050537, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24119TG2006PTC050537 | Current |
| U24119AP2006PTC050537 | Previous |
Key People
Mandapati Satyanarayana Reddy Managing Director Chandra Sekhara Reddi Director Bheemireddy Sridhar Reddy Director Recognitions & Rankings of Enanti Labs
Contact details
Enanti Labs Private Limited's registered office is in Hyderabad, Telangana. Its website is enantilabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFlat No. 201 Plot No. 10 Vivekananda Nagar Colony, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Enanti Labs Private Limited, buy the company report.
Comprehensive company report
Enanti Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Enanti Labs operates one associated brand: Enanti Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Enanti Labs produces pharmaceutical intermediates and APIs in India with quality focus. | enantilabs.com |
Business activity
The main business activity of Enanti Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Enanti Labs Private Limited, buy the company report.
Financials of Enanti Labs Private Limited
FY 2024 filings availableEnanti Labs Private Limited reported revenue of ₹62.07 Cr (down 14% YoY) for FY 2025.
Revenue · FY 2025
₹62.07 Cr ▼ 14%
Net profit · FY 2025
₹75.35 Lakh margin 1.2%
EBITDA · FY 2025
₹4.72 Cr margin 7.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 14%
3 years · compounded
▼ 12%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▼ 18%
3 years · compounded
▼ 5%
5 years · compounded
▲ 7%
Revenue fell 14% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.72 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹75.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.6% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Enanti Labs Private Limited, buy the company report.
Board of directors of Enanti Labs Private Limited
Enanti Labs has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandra Sekhara Reddi | Director | 05 Jul 2006 | 20 Years 4 Months | Current |
| Bheemireddy Sridhar Reddy | Director | 24 Aug 2006 | 20 Years 2 Months | Current |
| Mandapati Satyanarayana Reddy | Managing Director | 24 Aug 2006 | 20 Years 2 Months | Current |
Peer comparison
Enanti Labs Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Preet Remedies Limited | ₹62.83 Cr (FY 2025) | 18.0% | Chandigarh, India | |||
| Sri Gayathri Drugs Private Limited | ₹62.48 Cr (FY 2025) | 15.0% | Hyderabad, Telangana, India | |||
| Shamshree Lifesciences Limited | ₹62.27 Cr (FY 2025) | 10.0% | Chandigarh, India | |||
| Cian Healthcare Limited | ₹62.14 Cr (FY 2024) | -10.0% | Pune, Maharashtra, India | |||
| Enanti Labs Private Limitedthis company | ₹62.07 Cr (FY 2025) | ₹75.35 Lakh | 1.2% | -14.0% | 169 | Hyderabad, Telangana, India |
| MDC Pharmaceuticals Limited | ₹61.89 Cr (FY 2024) | 14.0% | Chandigarh, India | |||
| DNV Overseas Impex Private Limited | ₹61.67 Cr (FY 2018) | 74.0% | New Delhi, Delhi, India | |||
| Unijules Life Sciences Limited | ₹61.64 Cr (FY 2018) | -4.0% | Nagpur, Maharashtra, India |
To see the full peer comparison of Enanti Labs Private Limited, buy the company report.
Auditor
Enanti Labs Private Limited is audited by M N Reddy & Co., for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M N Reddy & Co., | FY 2023 | 010025S |
Shareholding
The shareholding of Enanti Labs Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Enanti Labs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹32.96 Cr
Satisfied charges
₹40.42 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Jan 2024 | 100868766 | Hdfc Bank Limited | ₹32.96 Cr | Open | |
| 29 Aug 2022 | 100612908 | Others | ₹52.89 Lakh | Satisfied | |
| 23 Aug 2022 | 100606527 | Others | ₹1.03 Cr | Satisfied | |
| 25 Jun 2021 | 100468320 | Others | ₹10.93 Cr | Satisfied | |
| 25 Jun 2021 | 100468315 | Others | ₹2.07 Cr | Satisfied |
To see the full charge records of Enanti Labs Private Limited, buy the company report.
Total charge records: 13 View all charges
Deals & funding
Enanti Labs Private Limited has 12 deals on record (8 secondary share transfers, 4 funding rounds), with disclosed funding of ₹6.67 Cr; the latest was in July 2021.
Total deals
12
Secondary share transfers
8
Funding rounds
4
Disclosed funding
₹6.67 Cr
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2021 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 3 individuals |
| Apr 2021 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Jan 2021 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: an individual |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 2 individuals |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 2 individuals |
To see the full deal history of Enanti Labs Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Enanti Labs Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Total cases
2
Filed against the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed against the company by Unified Technical Solutions | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by an individual | Disposed |
To see the full case history of Enanti Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Enanti Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Enanti Labs Private Limited has a workforce of 169 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
169
Active EPFO establishments
1
Employee growth
-2.9%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 169 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Enanti Labs Private Limited, buy the company report.
GST
Enanti Labs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AABCE6229K1ZG | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Enanti Labs Private Limited, buy the company report.
Recent activity
Enanti Labs Private Limited has 7 board changes on record since 2006: 3 appointments and 4 cessations. The latest: Uday Bhaskar Sistla ceased to be Additional Director on 02 Jul 2016.
Charges
A charge with Hdfc Bank Limited of Rs. 32.96 Cr registered on 22 Jan 2024 with Charge ID 100868766 was modified on 15 Mar 2025.
AGM
Enanti Labs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge registered on 08 May 2017 via Charge ID 100103670 with Others was fully satisfied on 03 Jul 2024.
Charges
A charge registered on 29 Aug 2022 via Charge ID 100612908 with Others was fully satisfied on 29 Apr 2024.
Filing
Enanti Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge registered on 23 Aug 2022 via Charge ID 100606527 with Others was fully satisfied on 15 Feb 2024.
Charges
A charge registered on 25 Jun 2021 via Charge ID 100468320 with Others was fully satisfied on 15 Feb 2024.
Charges
A charge registered on 25 Jun 2021 via Charge ID 100468315 with Others was fully satisfied on 15 Feb 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 32.96 Cr with Charge ID 100868766 was registered on 22 Jan 2024.
Charges
A charge with Others amounted to Rs. 0.53 Cr with Charge ID 100612908 was registered on 29 Aug 2022.
Charges
A charge with Others of Rs. 1.03 Cr registered on 23 Aug 2022 with Charge ID 100606527 was modified on 24 Aug 2022.
Charges
A charge with Others amounted to Rs. 1.03 Cr with Charge ID 100606527 was registered on 23 Aug 2022.
29 earlier events are in the company report.
Frequently asked questions
Enanti Labs is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 July 2006 (20+ years old) and is registered under CIN U24119TG2006PTC050537.
Enanti Labs has 3 current directors:
- Mandapati Satyanarayana Reddy - Managing Director
- Chandra Sekhara Reddi - Director
- Bheemireddy Sridhar Reddy - Director
The latest financial statements of Enanti Labs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Enanti Labs is 37AABCE6229K1ZG, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Enanti Labs is U24119TG2006PTC050537. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Enanti Labs has 2 court cases on record: 2 filed against it. 1 is pending.
Enanti Labs was incorporated on 05 July 2006, making it 20+ years old. It is registered with the Registrar of Companies, Hyderabad.
Enanti Labs has 12 deals on record (8 secondary share transfers, 4 funding rounds), with disclosed funding of ₹6.67 Cr; the latest was in July 2021.
The peers of Enanti Labs by revenue are Preet Remedies Limited, Sri Gayathri Drugs Private Limited, Shamshree Lifesciences Limited, Cian Healthcare Limited, MDC Pharmaceuticals Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Uday Bhaskar Sistla ceased to be Additional Director on 02 Jul 2016. Suryanarayana Reddy Maddireddy ceased to be Director on 10 Sep 2015. Vishnu Vardhan Reddy Pamula Pati ceased to be Director on 23 May 2009. Enanti Labs has 7 board changes on record in total.
Yes, Enanti Labs is registered as a medium enterprise under Udyam registration (number: UDYAM-AP-10-0000094).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages